U.S. Aerospace & Defense Stock News

Aveanna Healthcare Holdings Inc. recently reported past first-quarter 2026 results, with sales rising to US$647.92 million and net income to US$41.65 million, while basic and diluted EPS from continuing operations reached US$0.19. The company also recorded lower impairment charges than a year ago and slightly raised its full-year 2026 revenue outlook to a range of US$2.56 billion to US$2.58 billion, signaling management confidence despite prior dilution and unusual items affecting recent...

In the first quarter of 2026, Steel Dynamics reported record steel shipments, higher net and operating income, and revenue ahead of expectations, while management highlighted progress commissioning additional aluminum facilities and reaffirmed confidence in strong domestic demand for low‑carbon, locally produced materials. An interesting takeaway is how Steel Dynamics is positioning its expanding aluminum operations and integrated recycling capabilities to serve customers seeking...

In May 2026, Thermo Fisher Scientific Inc. held its 2026 Investor Day and affirmed a quarterly dividend of US$0.47 per share payable on July 15, 2026, while also updating investors on AI integration, capital deployment, and portfolio initiatives following recent leadership changes and the announced US$9.00 billion Clario acquisition. Beyond the dividend, the company’s focus on AI-enabled clinical and laboratory solutions, expanded bioanalytical capacity, and end-to-end drug development...

Amgen has confirmed that executive vice president and chief financial officer Peter Griffith will retire, with former Amgen finance leader Thomas Dittrich rejoining as executive vice president on July 1, 2026, and assuming the CFO role on September 1, 2026, while Griffith stays through January 2027 to support the transition. At the same time, shareholders recently voted against a proposal to require an independent board chair, underscoring investor attention on how Amgen balances board...

In May 2026, Fortive Corporation completed a US$1.10 billion senior unsecured fixed-rate notes offering, issuing 4.750% notes due 2031 and 5.250% notes due 2036, primarily to refinance its 3.150% senior notes maturing in June 2026 and for general corporate purposes. The new callable, unsubordinated notes extend Fortive’s debt maturity profile and modestly increase interest costs, while preserving financial flexibility for ongoing operations and potential future investments. We’ll now...

Why Schneider National (SNDR) is on investors’ radar Schneider National (SNDR) has drawn fresh attention after recent share price moves, with the stock last closing at $33.40. Investors are weighing this against its reported revenue of $5,671.0 million and net income of $97.9 million. See our latest analysis for Schneider National. Recent price action has been strong, with a 30-day share price return of 11.93% and a year to date share price return of 23.84%. The 1 year total shareholder...

In May 2026, Warby Parker announced its first AI-powered “Intelligent Eyewear” frame, developed with Google and Samsung, featuring Gemini integration and Android XR support for everyday, hands-free assistance. This move signals Warby Parker’s push beyond traditional eyewear into AI wearables while insider share sales add an extra layer of uncertainty around the shift. Now we’ll examine how Warby Parker’s Google- and Samsung-backed Intelligent Eyewear initiative could reshape its investment...

First quarter loss widens for Damora Therapeutics (DMRA) Damora Therapeutics (DMRA) reported first quarter results that drew attention, with a net loss of US$27.78 million for the period ended March 31, 2026, compared with US$2.53 million a year earlier. See our latest analysis for Damora Therapeutics. The share price has been volatile, with a 1 day share price return of 1.77% and year to date share price return of 15.95%. The 1 year total shareholder return is very large, but longer term...

MakeMyTrip (MMYT) is back in focus after its latest quarterly and full year 2026 results, where lower profit and an earnings miss contrasted with higher gross bookings, rising finance costs, and ongoing geopolitical pressures on travel demand. See our latest analysis for MakeMyTrip. The stock’s recent slide, including a 30 day share price return of down 6.82% and a year to date share price return of down 47.8%, contrasts sharply with a 3 year total shareholder return of 62.12%. This suggests...

Spire Global (SPIR) is back on investor radar after two business updates: an expanded Cirrus weather intelligence offering for energy traders and a new aircraft tracking data agreement with Amadeus IT Group. See our latest analysis for Spire Global. The share price has moved to US$21.16 after a 10.15% 1 day share price return and a 129.75% 90 day share price return, alongside a 1 year total shareholder return of 98.87%, reflecting strong momentum despite the recent earnings shortfall and...

In May 2026, Immunovant, Inc. reported a wider quarterly and full-year net loss, with fourth-quarter net loss rising to US$147.86 million and full-year net loss to US$505.61 million, while maintaining a cash balance above US$900 million and recording no revenue. At the same time, Immunovant released encouraging Week 16 data for its lead FcRn inhibitor IMVT-1402 in difficult-to-treat rheumatoid arthritis and discontinued batoclimab after Phase 3 failures, signaling a concentrated push behind...

Earlier in May 2026, Teva Pharmaceutical Industries presented new real-world data from its three-year IMPACT-TD Registry at the American Psychiatric Association meeting, revealing that young adults with mood disorders and tardive dyskinesia often face delayed recognition and low formal diagnosis rates despite substantial daily life impact. The findings underline a pronounced diagnostic gap in tardive dyskinesia for patients under 40, especially those aged 18–29, who report high psychological...

Earlier this week, ESAB introduced the Sentinel A70 PRO, its first premium flip-up automatic welding helmet for heavy industry, featuring dual flip-up functionality, advanced optics, integrated lighting, Bluetooth connectivity, and second-generation True-Color auto-darkening technology designed to enhance comfort and productivity. The launch underscores ESAB’s push to differentiate through higher-tech equipment at a time when analysts remain concerned about its limited organic revenue growth...

Popular (BPOP) has drawn fresh attention after two years of expanding net interest margin, strong quarterly results and annualized EPS growth of 30.9%, with recent options activity pointing to expectations of sharper share price moves. See our latest analysis for Popular. Recent governance changes at the annual meeting and a renewed performance focus from management sit alongside a 19.5% year to date share price return and a 50.5% 1 year total shareholder return, indicating momentum that...

Rising mortgage rates recently hit a one month high, stirring fresh worries about housing affordability and future demand. Griffon (GFF), a home construction materials company, dropped 3.9% in that session as investors reassessed sector risks. See our latest analysis for Griffon. Despite the recent drop on mortgage rate concerns, Griffon’s recent 7 day share price return of 3.7% and year to date share price return of 13.11% contrast with its 30 day share price decline of 6.83%, while the 1...

Brookfield Wealth Solutions Ltd. reported first-quarter 2026 results, with revenue of US$1.66 billion down from US$2.62 billion a year earlier and a wider net loss of US$609 million versus US$326 million, signaling a tougher operating period. The combination of sharply lower revenue and a much larger loss suggests the business is facing meaningful pressure on both growth and profitability drivers. Next, we’ll examine how this steep revenue drop and expanding loss profile shape Brookfield...

Record quarter puts HCI Group (HCI) in focus HCI Group (HCI) has drawn fresh attention after reporting the best first quarter in its history, pairing record profitability and cash flows with the start of a US$80 million share repurchase program. See our latest analysis for HCI Group. Despite the record quarter and active US$80 million buyback, recent share price returns have been mixed. The stock is down year to date but supported by a strong three year total shareholder return above 200%,...

Nuvalent recently presented pivotal ALKOVE-1 data for neladalkib in TKI pre-treated advanced ALK-positive NSCLC and preliminary ARROS-1 data for zidesamtinib in ROS1-positive solid tumors other than NSCLC at the 2026 ASCO Annual Meeting, supporting its recent FDA NDA submission and ongoing Phase 3 ALKAZAR trial. An interesting angle is how zidesamtinib’s early results in ROS1-positive tumors beyond lung cancer highlight Nuvalent’s effort to broaden targeted therapy applications. We’ll now...

Earlier this week, Western Digital announced that its newest high-capacity Ultrastar DC HC6100 UltraSMR hard drives now integrate NIST-approved post-quantum cryptography, adding PQC-ready secure boot and firmware protection that are currently being qualified by multiple hyperscale customers. This move brings quantum-resistant security out of the lab and into production storage hardware, potentially redefining how AI data centers think about long-term device-level trust and infrastructure...

Solaris Energy Infrastructure (SEI) has just paired a nearly US$2b financing package with a sizable contract expansion, adding 130 MW and lifting its total contracted project investment by more than 60%. See our latest analysis for Solaris Energy Infrastructure. SEI’s share price has climbed 50.83% over the past 90 days and 47.77% year to date, while its 1 year total shareholder return of 178.07% points to strong momentum around the stock’s story. If this kind of contract-backed growth...

Target reported past first-quarter 2026 results with net sales of US$25,443 million, up from US$23,846 million a year earlier, while net income fell to US$781 million as earnings per share declined despite stronger comparable and digital sales. The company also raised its 2026 outlook, now projecting net sales growth around 4% versus 2025 and GAAP EPS near the high end of its prior US$7.50–US$8.50 range, underscoring management’s confidence while activist investors question board oversight...

What recent performance data says about ANI Pharmaceuticals stock With no single headline event driving attention, investors are looking at how ANI Pharmaceuticals (ANIP) has been trading recently and how that lines up with its current fundamentals and valuation signals. Over the past week, the stock gained about 6%, with returns of roughly 3% over the past month and 6% over the past 3 months. Year to date, ANI Pharmaceuticals is up about 5%, while its 1 year total return is around...

Rogers Corporation recently appointed Ali El-Haj as its President, Chief Executive Officer and a member of the Board, formalizing his role after serving as interim CEO and aligning his compensation with a US$750,000 base salary, a target annual incentive equal to base pay, and a US$5,000,000 long-term equity grant. The Board’s decision ties a substantial portion of El-Haj’s pay to multi-year restricted stock units, signaling a focus on longer-term performance and closer alignment between...

Earlier this month, UBS upgraded Alcoa Corporation to Buy, citing expectations that prolonged aluminium supply disruptions from the Middle East will tighten global markets and support the company’s pricing power and earnings potential. This upgrade highlights how geopolitical risks in key producing regions can rapidly reframe the outlook for an already cost‑pressured, capital‑intensive aluminium producer like Alcoa. We’ll now examine how UBS’s supply-disruption thesis interacts with Alcoa’s...